Proteomics International is pleased to provide a copy of the investor presentation released today fo...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
We are pleased to release a recording of the Proteomics International Annual General Meeting to shar...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International is pleased to share a copy of the Investor Webinar and Q&A session held on ...
Proteomics International is pleased to share a copy of the Investor Webinar and Q&A session held on ...
Proteomics International attended the Australasian Diabetes Congress conference at the Adelaide Conv...
Proteomics International Laboratories Ltd is pleased to provide a copy of the presentation made at t...
Proteomics International Laboratories Ltd is pleased to provide a copy of the presentation made toda...
We are pleased to release a copy of the Chairman’s Address provided by Mr Neville Gardiner and the I...
The Company is pleased to release a copy of the presentation by Managing Director Dr Richard Lipscom...
The Company is pleased to provide an opportunity for shareholders and investors to view a virtual pr...
The Company is pleased release a copy of its latest investor presentation updated for recent develop...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International’s 2021 Annual General Meeting of Shareholders was held on Thursday, 25 Nove...
Proteomics International presented an ePoster at ASN Kidney Week 2021. Over 10,000 nephrologists, ph...
PromarkerD, the only low cost, high speed test capable of predicting the onset of diabetic kidney di...
Proteomics International displayed a virtual booth at the 57th European Association for the Study of...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
Proteomics International will showcase PromarkerD at the Australasian Diabetes Congress, the largest...
Proteomics International showcased PromarkerD at the American Diabetes Association’s 81st Scientific...
Proteomics International will be showcasing PromarkerD at the 58th ERA-EDTA Congress, Europe’s leadi...
Proteomics International attended the Professional Society for Health Economics and Outcomes Researc...
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to release...
PromarkerD, the only low cost, high speed test capable of predicting the onset of diabetic kidney di...
PromarkerD, the only low cost, high speed test capable of predicting the onset of diabetic kidney di...
Proteomics International attended the Lorne Proteomics 2021 Virtual symposium. The Company has been ...
Managing Director Dr Richard Lipscombe gave a presentation at the 2020 AGM highlighting the progress...
Proteomics International showcased PromarkerD, the predictive test for diabetic kidney disease, at A...
The Company sponsored and attended the inaugural AGM for the Perth Protein Group, a special interest...
Investor Presentation – August 2020
Your browser does not support the audio element.
In 2020, the American Diabetes Association’s 80th Scientific Sessions was a virtual conference (June...
Investor Presentation
Investor Presentation
Proteomics International is proud to announce that it has received recognition for its continued exp...
PromarkerD was showcased at the 55th Annual Meeting of the European Association for the Study of Dia...
Proteomics International attended the 18th Human Proteome Organization World Congress, September 15t...
Proteomics International presented at the 121 Tech Investment Summit in Hong Kong. The 121 Summit is...
Proteomics International was invited to feature on the American Diabetes Association (ADA) TV News N...
Proteomics International showcased PromarkerD at BIO International Convention – Philadelphia, June 3...
Proteomics International is at AusBiotech 2018 at the Brisbane Convention and Exhibition Centre, Sou...
Proteomics International is proud to announce that it has received recognition for its export succes...
Proteomics International (PI) is pleased to announce that Dr Javed Khan (Business Development/Comput...
Proteomics International (PI) is pleased to announce that Dr Richard Lipscombe (Managing Director), ...
Proteomics International gave a presentation as part of the QEII BioInnovation Showcase and Partneri...
Proteomics International was at Ausbiotech 2017, from 25th to 27th October 2017, at the Adelaide Con...
Proteomics International attended the 16th Human Proteome Organisation World Congress (HUPO) in Dubl...
Proteomics International attended and presented at the Australian Diabetes Society (ADS)/Australian ...
Dr Javed Khan (Business Development/Computational Proteomics Scientist), Mr. Shane Herbert (Customer...
Proteomics International attended the International Proteomics Conference 2017 “Proteomics in Biotec...
Global leader in predictive diagnostics
Canary Capital will be hosting a PIQ Investor Event at its office in Sydney with Dr Richard Lipscomb...
Proteomics International presented its PromarkerD validation clinical study results at the American ...
Dr Richard Lipscombe (Managing Director), Dr Javed Khan (Business Development/Computational Proteomi...
Proteomics International (PI) is pleased to announce that Dr Richard Lipscombe (Managing Director), ...
Managing director Dr Richard Lipscombe showcasing the company and PromarkerD, the world leading pred...
Managing director Dr Richard Lipscombe showcased the company and PromarkerD, the world leading predi...
Global leader in predictive diagnostics
Proteomics International, the leader in predictive diagnostics for diabetic kidney disease, will adv...
Proteomics International (PI) is pleased to announce that Managing Director Dr Richard Lipscombe and...
Proteomics International Laboratories Ltd (PILL) edged out shipbuilding giant Austal and Fortescue M...
Global leader in applying proteomics to MedTech
Proteomics International’s Contract Services Manager Ms Andreja Livk and Computational Proteomics Sp...
Managing Director, Dr Richard Lipscombe presents “Emerging Mass Spectrometry Approaches To Cancer Bi...
The Company conducted a trade visit to India, from the 18th to the 28th April, to promote its biosim...
Proteomics International continues to market PromarkerD in major global markets. Dr Richard Lipscomb...
Proteomics International Attends Trade Show and Presents at the 21st Annual Lorne Proteomics Symposi...
Proteomics International presents PromarkerD – a predictive test for the diagnosis of diabetic kidne...
Global leader & innovator in the field of proteomics
Proteomics International Invited to Attend the 6th China International Medical Expo
Managing director, Dr Richard Lipscombe Presents at the 11th Australian Peptide Conference 2015
Proteomics International Attends Trade Show at the 20th Annual Lorne Proteomics Conference 2014
Proteomics International Attends Trade Shows at the Arab Health 2014 & Diabetes Conference in Dubai
Representing Proteomics International, Dr Roopwant Judge (Business Development) visited clients in H...
Proteomics International Attends Trade Shows at Next Generation Diagnostics Summit Washington 2013
Proteomics International attends Biologics World Korea 2013
Proteomics International attends BioAsia India 2013
Dr Richard Lipscombe (Managing Director) Chaired day 2 of the conference, giving the opening and clo...
Kaye Winfield (MSc) (Lab Manager) presented in the Poster Sessions.
Proteomics International exhibited in the Trade Display and presented R&D outcomes in the Poster Ses...
Dr Richard Lipscombe gave the Opening Keynote Address. Title: “Plasma Biomarkers for Diabesity: Disc...
Proteomics International exhibited in the Trade Display and presented R&D outcomes in the Poster Ses...
Dr Richard Lipscombe presented a model workflow for biomarkers. Title: “Plasma Biomarkers for Diabes...
Proteomics International shared a booth with colleagues from Metabolomics Australia, and Dr Scott Br...